蛋白酶

CAS号：668270-12-0

品名：利格列汀linagliptin

中文别名：8-[(3R)-3-氨基-1-哌啶基]-7-(2-丁炔基)-3,7-二氢-3-甲基-1-[(4-甲基-2-喹唑啉基)甲基]-1H-嘌呤-2,6-二酮;利拉利汀;

英文别名：Trajenta;BI-1356-BS;8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione;Ondero;BI-1356;Tradjenta;Linagliptin;

分子式：C25H28N8O2

分子量：472.542

精确质量：472.234

Psa：116.86

MDL号：MFCD14635356

密度：1.39

沸点：661.189ºC at 760 mmHg

熔点：202ºC

闪点：353.675ºC

折射率：1.717

简介：Anovelpotentandselectivedipeptidylpeptidase-4(DPP-4)inhibitorwithpotentialuseinthetreatmentoftype2diabetes.

蛋白酶

CAS号：1009119-64-5

品名：达卡他韦daclatasvir

中文别名：N,N'-[[1,1'-联苯]-4,4'-二基双[1H-咪唑-5,2-二基-(2S)-2,1-吡咯烷二基[(1S)-1-(1-甲基乙基)-2-氧代-2,1-乙烷二基]]]双氨基甲酸C,C'-二甲酯;

英文别名：Carbamicacid,N,​N'-​[[1,​1'-​biphenyl]​-​4,​4'-​diylbis[1H-​imidazole-​5,​2-​diyl-​(2S)​-​2,​1-​pyrrolidinediyl[(1S)​-​1-​(1-​methylethyl)​-​2-​oxo-​2,​1-​ethanediyl]​]​]​bis-​,C,​C'-​dimethylester;N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2S)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamicacidC,C'-dimethylester;BMS-790052;EBP883;Daclatasvir;

分子式：C40H50N8O6

分子量：738.875

精确质量：738.385

Psa：174.64

UNII号：LI2427F9CI

密度：1.249

简介：Daclatasvir(USAN,formerlyBMS-790052,tradenameDaklinza)isadrugforthetreatmentofhepatitisC(HCV).ItwasdevelopedbyBristol-MyersSquibbandwasapprovedinEuropeon22August2014.DaklinzagaineditsFDAapprovalonJuly24,2015intheUnitedStates;itisapprovedforHepatitisCgenotype3infections.